Flow Cytometry Shared Resource

Published Research

Citation Reference Language for Use of Shared Resource

Example citation: “The Flow Cytometry Shared Resource services are supported by the Comprehensive Cancer Center of Wake Forest Baptist Medical Center, NCI CCSG P30CA012197 grant.”


Program Key: CPC = Cancer Prevention and Control Program; CRP = Clinical Research Program; TPR = Tumor Progression and Recurrence Program; CBB = Cancer Biology and Biochemistry Program

  1. Wu K, Fukuda K, Xing F, Zhang Y, Sharma S, Liu Y, Chan MD, Zhou X, Qasem SA, Pochampally R, Mo YY, Watabe K (TPR).  Roles of the cyclooxygenase 2 matrix metalloproteinase 1 pathway in brain metastasis of breast cancer. J. Biol. Chem. 2015;290(15):9842-54. PMC4392281.
  2. Swanner J, Mims J, Carroll DL, Akman SA (CRP), Furdui CM (CBB), Torti SV (CBB), Singh RN (CBB). Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells. Int J Nanomedicine. 2015. 10:3937-53. PMC4501353.
  3. Pardee T (CRP), Stadelman K, Jennings-Gee J, Caudell D (CRP), and Gmeiner W (CBB). The poison oligonucleotide F10 is highly effective against acute lymphoblastic leukemia while sparing normal hematopoietic cells. Oncotarget. 2014; 5: 4170-4179. PMC4147314.
  4. Sinan, Z, Mott RT, Fry EA, Taneja P, Kulik G (TPR), Sui G (TPR), and Inoue K. Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer. Am J Pathol. 2013; 183:1339-1350. PMC3791682.
  5. Boyacioglu I, Stuart CH, Kulik G (TPR), Gmeiner WH (CBB). Dimeric DNA aptamer complexes for high-capacity–targeted drug delivery using pH-sensitive covalent linkages. Mol Ther-Nucl Acids. 2013; 2:e107. PMC3731884.
  6. Tang S, Moore ML, Grayson JM (TPR), Dubey P (TPR). Increased CD8+ T-cell function following castration and immunization is countered by parallel expansion of regulatory T cells. Cancer Res. 2012; 72:1975-85. PMC3690568.
  7. Lewis EM, Wilkinson AS, Jackson JS, Mehra R, Varambally S, Chinnaiyan AM, Wilkinson JC (TPR). The enzymatic activity of apoptosis-inducing factor supports energy metabolism benefiting the growth and invasiveness of advanced prostate cancer cells. J Biol Chem. 2012; 287:43862-43875. PMC3527969.
  8. Pardee TS (CRP), Gomes E, Jennings-Gee J, Caudell D (CRP), Gmeiner WH (CBB). Unique dual targeting of thymidylate synthase and topoisomerase1 by FdUMP[10] results in high efficacy against AML and low toxicity. Blood. 2012;119:3561-70. PMC3325043.

Quick Reference

Flow Cytometry Shared Resource

Lab 336-716-9465

James Wood



Martha Alexander-Miller



Beth Holbrook



Find A Doctor Ways to Give
Last Updated: 05-12-2016
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.